HRMY
Harmony Biosciences Holdings, Inc.
Company overview
- Market capitalization
- $2.33B
- Employees
- 293
- Latest publication
- 2026-09-29
About Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also develops Pitolisant that is in Phase 3 clinical trial for the treatment of Prader-Willi Syndrome (PWS); in Phase 2 clinical trial to treat Myotonic Dystrophy (DM1); and is in Phase 2 clinical trials for the treatment of Pitolisant Gastro-Resistant (GR) and Pitolisant High-Dose (HD). In addition, the company's products under development include BP1.15205, an orexin 2 receptor agonist for the treatment of narcolepsy and other potential indications; and HBS-102, a melanin-concentrating hormone receptor type 1 (MCHR1) antagonist. Further, it develops ZYN-002 that is in a Phase 3 registrational trial for the treatment of Fragile X Syndrome; and 22q Deletion Syndrome, a disorder caused by a small missing piece on the long arm of the 22nd chromosome. Additionally, the company is developing EPX-100 (clemizole hydrochloride), a serotonin (5HT-2) receptor agonist to treat dravet syndrome and lenox-gastaut syndrome; EPX-200 (liquid formulation of lorcaserin), a selective 5HT-2C agonist to treat developmental and epileptic encephalopathies; CBS105 for the treatment-resistant narcolepsy; and CBS104 for refractory epilepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 261,280,000USD | 215,387,000USD | 243,776,000USD | 239,455,000USD | 200,489,000USD | 184,733,000USD | 201,267,000USD | 186,038,000USD |
| Cost Of Revenue | 63,198,000USD | 44,512,000USD | 68,545,000USD | 59,650,000USD | 38,153,000USD | 31,994,000USD | 54,409,000USD | 42,778,000USD |
| Gross Profit | 198,082,000USD | 170,875,000USD | 175,231,000USD | 179,805,000USD | 162,336,000USD | 152,739,000USD | 146,858,000USD | 143,260,000USD |
| Research Development | 46,596,000USD | 69,383,000USD | 49,933,000USD | 54,962,000USD | 50,159,000USD | 34,540,000USD | 34,666,000USD | 25,387,000USD |
| Selling And Marketing Expenses | 34,120,000USD | 31,694,000USD | 29,179,000USD | 29,549,000USD | 30,073,000USD | 30,711,000USD | 27,600,000USD | 27,576,000USD |
| General And Administrative Expenses | 28,050,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 108,766,000USD | 133,584,000USD | 136,674,000USD | 114,318,000USD | 114,156,000USD | 96,494,000USD | 91,131,000USD | 81,550,000USD |
| Operating Income | 89,316,000USD | 37,291,000USD | 38,557,000USD | 65,486,999USD | 48,180,000USD | 56,245,000USD | 55,727,000USD | 61,710,000USD |
| Total Other Income Expense Net | 3,949,000USD | 2,396,000USD | 2,203,000USD | 2,003,000USD | 1,457,000USD | 932,000USD | 428,000USD | 460,000USD |
| Interest Expense | 3,070,000USD | 3,234,000USD | 3,546,000USD | 3,621,000USD | 3,646,000USD | 3,836,000USD | 4,209,000USD | 4,348,000USD |
| Income Before Tax | 93,265,000USD | 39,687,000USD | 40,760,000USD | 67,490,000USD | 49,637,000USD | 57,177,000USD | 56,155,000USD | 62,170,000USD |
| Income Tax Expense | 17,834,000USD | 7,199,000USD | 18,274,000USD | 16,625,000USD | 9,861,000USD | 11,617,000USD | 6,680,000USD | 16,077,000USD |
| Net Income | 75,431,000USD | 32,488,000USD | 22,486,000USD | 50,865,000USD | 39,776,000USD | 45,560,000USD | 49,475,000USD | 46,093,000USD |
| Selling General Administrative | — | 32,507,000USD | 57,562,000USD | 29,807,000USD | 33,924,000USD | 31,243,000USD | 28,865,000USD | 28,587,000USD |
| Interest Income | — | 5,757,000USD | 5,854,000USD | 5,730,000USD | 5,296,000USD | 5,044,000USD | 4,477,000USD | 4,932,000USD |
| Net Interest Income | — | 2,523,000USD | 2,308,000USD | 2,109,000USD | 1,650,000USD | 1,208,000USD | 268,000USD | 584,000USD |
| Tax Provision | — | 7,199,000USD | 18,274,000USD | 16,625,000USD | 9,861,000USD | 11,617,000USD | 6,680,000USD | 16,077,000USD |
| Net Income From Continuing Ops | — | 32,488,000USD | 22,486,000USD | 50,865,000USD | 39,776,000USD | 45,560,000USD | 49,475,000USD | 46,093,000USD |
| Ebit | — | 42,921,000USD | 44,306,000USD | 67,490,000USD | 53,283,000USD | 61,013,000USD | 60,364,000USD | 66,518,000USD |
| Ebitda | — | 48,889,000USD | 51,738,000USD | 73,458,000USD | 59,250,000USD | 66,981,000USD | 66,332,000USD | 72,486,000USD |
| Depreciation And Amortization | — | 5,968,000USD | 7,432,000USD | 5,968,000USD | 5,967,000USD | 5,968,000USD | 5,968,000USD | 5,968,000USD |
| Reconciled Depreciation | — | 5,968,000USD | 7,432,000USD | 5,968,000USD | 5,967,000USD | 5,968,000USD | 5,968,000USD | 5,968,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Total Revenue | 868,453,000USD | 714,734,000USD | 582,022,000USD | 437,855,000USD | 305,440,000USD |
| Cost Of Revenue | 198,342,000USD | 156,815,000USD | 121,236,000USD | 83,481,000USD | 55,518,000USD |
| Gross Profit | 670,111,000USD | 557,919,000USD | 460,786,000USD | 354,374,000USD | 249,922,000USD |
| Research Development | 189,594,000USD | 145,825,000USD | 76,063,000USD | 70,886,000USD | 30,367,000USD |
| Selling General Administrative | 152,536,000USD | 110,352,000USD | 95,289,000USD | 84,017,000USD | 63,909,000USD |
| Selling And Marketing Expenses | 119,512,000USD | 110,916,000USD | 97,404,000USD | 79,285,000USD | 68,118,000USD |
| Total Operating Expenses | 461,642,000USD | 367,093,000USD | 268,756,000USD | 234,188,000USD | 162,394,000USD |
| Operating Income | 208,469,000USD | 190,826,000USD | 192,030,000USD | 120,186,000USD | 87,528,000USD |
| Interest Income | 21,924,000USD | 18,542,000USD | 14,730,000USD | 3,126,000USD | 224,000USD |
| Interest Expense | 14,649,000USD | 17,496,000USD | 23,757,000USD | 18,795,000USD | 24,194,000USD |
| Net Interest Income | 7,275,000USD | 1,046,000USD | -11,910,000USD | -15,669,000USD | -23,970,000USD |
| Income Before Tax | 215,064,000USD | 191,804,000USD | 173,396,000USD | 104,686,000USD | 37,428,000USD |
| Income Tax Expense | 56,377,000USD | 46,311,000USD | 44,543,000USD | -76,782,000USD | 2,831,000USD |
| Tax Provision | 56,377,000USD | 46,311,000USD | 27,055,000USD | -76,782,000USD | 2,831,000USD |
| Net Income | 158,687,000USD | 145,493,000USD | 128,853,000USD | 181,468,000USD | 34,597,000USD |
| Net Income From Continuing Ops | 158,687,000USD | 145,493,000USD | 150,755,000USD | 181,468,000USD | 34,597,000USD |
| Ebit | 229,713,000USD | 209,300,000USD | 197,153,000USD | 123,481,000USD | 61,622,000USD |
| Ebitda | 255,048,000USD | 233,412,000USD | 221,512,000USD | 146,866,000USD | 80,462,000USD |
| Depreciation And Amortization | 25,335,000USD | 24,112,000USD | 24,359,000USD | 23,385,000USD | 18,840,000USD |
| Reconciled Depreciation | 25,335,000USD | 24,112,000USD | 24,302,000USD | 23,385,000USD | 18,840,000USD |
| Total Other Income Expense Net | 6,595,000USD | 978,000USD | -18,634,000USD | -15,500,000USD | -50,100,000USD |
| Non Operating Income Net Other | — | — | — | 169,000USD | -26,130,000USD |
| Net Income Applicable To Common Shares | — | — | — | 181,468,000USD | 34,597,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,373,084,000USD | 1,271,824,000USD | 1,271,631,000USD | 1,208,218,000USD | 1,108,008,000USD | 1,055,535,000USD | 999,200,000USD | 928,135,000USD |
| Cash And Equivalents | 549,769,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 667,791,000USD | 640,918,000USD | 775,340,000USD | 672,581,000USD | 565,274,000USD | 506,953,000USD | 467,186,000USD | 410,476,000USD |
| Short Term Investments | 118,022,000USD | 51,520,000USD | 22,838,000USD | 25,582,000USD | 19,224,000USD | 17,955,000USD | 14,185,000USD | 23,109,000USD |
| Long Term Investments | 294,668,000USD | 229,555,000USD | 107,127,000USD | 105,831,000USD | 107,008,000USD | 103,245,000USD | 108,874,000USD | 94,222,000USD |
| Total Current Assets | 814,334,000USD | 778,817,000USD | 907,014,000USD | 838,800,000USD | 691,354,000USD | 642,692,000USD | 579,252,000USD | 522,405,000USD |
| Other Current Assets | 9,877,000USD | 24,396,000USD | 29,530,000USD | 58,686,000USD | 26,999,000USD | 23,386,000USD | 21,835,000USD | 23,512,000USD |
| Other Non Current Assets | 29,821,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 373,841,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 234,070,000USD | 217,340,000USD | 252,132,000USD | 223,403,000USD | 180,135,000USD | 175,118,000USD | 175,082,000USD | 161,279,000USD |
| Other Current Liabilities | 11,167,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 5,810,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 999,243,000USD | 910,349,000USD | 870,218,000USD | 835,123,000USD | 773,080,000USD | 720,525,000USD | 659,155,000USD | 596,804,000USD |
| Total Equity Including Noncontrolling Interest | 999,243,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 20,000,000USD | 20,000,000USD | 20,000,000USD | 20,000,000USD | 18,750,000USD | 17,500,000USD | 16,250,000USD | 15,000,000USD |
| Long Term Debt | 133,961,000USD | 138,814,000USD | 143,663,000USD | 148,506,000USD | 153,345,000USD | 158,182,000USD | 163,016,000USD | 167,847,000USD |
| Net Receivables | 110,995,000USD | 108,222,000USD | 96,787,000USD | 100,651,000USD | 92,981,000USD | 105,969,000USD | 83,033,000USD | 81,502,000USD |
| Inventory | 6,360,000USD | 5,281,000USD | 5,357,000USD | 6,882,000USD | 6,100,000USD | 6,384,000USD | 7,198,000USD | 6,915,000USD |
| Intangible Assets | 77,496,000USD | 83,457,000USD | 89,418,000USD | 95,380,000USD | 101,341,000USD | 107,302,000USD | 113,263,000USD | 119,225,000USD |
| Accounts Payable | 21,684,000USD | 28,600,000USD | 17,693,000USD | 26,341,000USD | 28,301,000USD | 17,459,000USD | 13,744,000USD | 10,532,000USD |
| Common Stock | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Retained Earnings | 268,822,000USD | 193,391,000USD | 160,903,000USD | 138,417,000USD | 87,552,000USD | 47,776,000USD | 2,216,000USD | -47,259,000USD |
| Accumulated Other Comprehensive Income | -727,000USD | -413,000USD | 346,000USD | 357,000USD | 239,000USD | 244,999USD | 66,000USD | 499,000USD |
| Total Liab | — | 361,475,000USD | 401,413,000USD | 373,095,000USD | 334,928,000USD | 335,010,000USD | 340,045,000USD | 331,331,000USD |
| Other Current Liab | — | 125,567,000USD | 147,547,000USD | 176,237,000USD | 132,238,000USD | 139,011,000USD | 143,770,000USD | 134,215,000USD |
| Capital Stock | — | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Cash | — | 589,398,000USD | 752,502,000USD | 646,999,000USD | 546,050,000USD | 488,998,000USD | 453,001,000USD | 387,367,000USD |
| Net Debt | — | -382,883,000USD | -512,923,000USD | -477,265,000USD | -372,677,000USD | -311,534,000USD | -271,595,000USD | -202,125,000USD |
| Short Term Debt | — | 63,173,000USD | 86,892,000USD | 20,825,000USD | 19,596,000USD | 18,648,000USD | 17,568,000USD | 16,532,000USD |
| Short Long Term Debt Total | — | 206,515,000USD | 239,579,000USD | 169,734,000USD | 173,373,000USD | 177,464,000USD | 181,406,000USD | 185,242,000USD |
| Property Plant Equipment Net | — | 5,388,000USD | 5,344,000USD | 2,668,000USD | 2,653,000USD | 3,104,000USD | 3,379,000USD | 3,070,000USD |
| Common Stock Shares Outstanding | — | 58,776,297shares | 58,696,342shares | 58,717,910shares | 58,427,134shares | 58,524,566shares | 58,218,000shares | 58,104,000shares |
| Non Current Assets Total | — | 493,007,000USD | 364,617,000USD | 369,418,000USD | 416,654,000USD | 412,843,000USD | 419,948,000USD | 405,730,000USD |
| Non Current Liabilities Total | — | 144,135,000USD | 149,281,000USD | 149,692,000USD | 154,793,000USD | 159,892,000USD | 164,963,000USD | 170,052,000USD |
| Non Current Liabilities Other | — | 5,321,000USD | 5,618,000USD | 1,186,000USD | 1,448,000USD | 1,710,000USD | 1,947,000USD | 2,205,000USD |
| Non Currrent Assets Other | — | 20,775,000USD | 12,759,000USD | 165,539,000USD | 205,652,000USD | 199,192,000USD | 194,432,000USD | 189,213,000USD |
| Net Working Capital | — | 561,477,000USD | 654,882,000USD | 615,397,000USD | 511,219,000USD | 467,574,000USD | 404,170,000USD | 361,126,000USD |
| Unclassified Non Current Assets | — | 153,832,000USD | 149,969,000USD | — | — | — | — | — |
| Unclassified Current Liabilities | — | -20,000,000USD | -20,000,000USD | -20,000,000USD | -18,750,000USD | -17,500,000USD | -16,250,000USD | -15,000,000USD |
| Unclassified Equity | — | 717,369,000USD | 708,967,000USD | 696,347,000USD | 685,287,000USD | 672,502,001USD | 656,871,000USD | 643,562,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | -10,532,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,271,631,000USD | 999,200,000USD | 811,448,000USD | 673,870,000USD | 433,443,000USD | 427,074,000USD | 106,703,000USD | 89,282,000USD |
| Intangible Assets | 89,418,000USD | 113,263,000USD | 137,108,000USD | 160,953,000USD | 143,919,000USD | 162,343,000USD | 72,185,000USD | — |
| Other Current Assets | 29,530,000USD | 21,835,000USD | 18,107,000USD | 18,133,000USD | 10,855,000USD | 8,261,000USD | 1,697,000USD | 3,161,000USD |
| Total Liab | 401,413,000USD | 340,045,000USD | 344,456,000USD | 271,032,000USD | 246,936,000USD | 329,894,000USD | 118,288,000USD | 7,754,000USD |
| Total Stockholder Equity | 870,218,000USD | 659,155,000USD | 466,992,000USD | 402,838,000USD | 186,507,000USD | 97,180,000USD | -11,585,000USD | 81,528,000USD |
| Other Current Liab | 147,547,000USD | 143,770,000USD | 131,051,000USD | 73,098,000USD | 49,414,001USD | 131,983,000USD | 13,532,000USD | 5,769,000USD |
| Common Stock | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Capital Stock | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 411,277,000USD | 324,201,000USD |
| Retained Earnings | 160,903,000USD | 2,216,000USD | -143,277,000USD | -272,130,000USD | -453,598,000USD | -488,195,000USD | -422,862,000USD | -242,673,000USD |
| Cash | 752,502,000USD | 453,001,000USD | 311,660,000USD | 243,784,000USD | 234,309,000USD | 228,631,000USD | 24,457,000USD | 83,523,000USD |
| Cash And Short Term Investments | 775,340,000USD | 467,186,000USD | 353,460,000USD | 323,115,000USD | 234,309,000USD | 228,631,000USD | 24,457,000USD | 83,523,000USD |
| Total Current Assets | 907,014,000USD | 579,252,000USD | 451,070,000USD | 400,285,000USD | 284,439,000USD | 262,891,000USD | 31,497,000USD | 86,684,000USD |
| Total Current Liabilities | 252,132,000USD | 175,082,000USD | 163,781,000USD | 78,884,000USD | 53,775,000USD | 134,539,000USD | 19,892,000USD | 7,231,000USD |
| Net Debt | -512,923,000USD | -271,595,000USD | -118,094,000USD | -52,137,000USD | -38,565,000USD | -34,381,000USD | 73,489,000USD | 240,678,000USD |
| Short Term Debt | 86,892,000USD | 17,568,000USD | 15,000,000USD | 2,000,000USD | 3,360,000USD | — | — | — |
| Short Long Term Debt | 20,000,000USD | 16,250,000USD | 15,000,000USD | 2,000,000USD | 2,000,000USD | — | — | — |
| Short Long Term Debt Total | 239,579,000USD | 181,406,000USD | 193,566,000USD | 191,647,000USD | 195,744,000USD | 194,250,000USD | 97,946,000USD | 324,201,000USD |
| Long Term Debt | 143,663,000USD | 163,016,000USD | 178,566,000USD | 189,647,000USD | 189,984,000USD | 194,250,000USD | 97,946,000USD | — |
| Long Term Investments | 107,127,000USD | 108,874,000USD | 72,169,000USD | 22,568,000USD | 0USD | — | — | — |
| Short Term Investments | 22,838,000USD | 14,185,000USD | 41,800,000USD | 79,331,000USD | 0USD | — | — | — |
| Net Receivables | 96,787,000USD | 83,033,000USD | 74,140,000USD | 54,740,000USD | 34,843,000USD | 22,176,000USD | 4,255,000USD | 0USD |
| Inventory | 5,357,000USD | 7,198,000USD | 5,363,000USD | 4,297,000USD | 4,432,000USD | 3,823,000USD | 1,088,000USD | 0USD |
| Accounts Payable | 17,693,000USD | 13,744,000USD | 17,730,000USD | 3,786,000USD | 1,000,999USD | 2,556,000USD | 6,360,000USD | 1,462,000USD |
| Property Plant Equipment Net | 5,344,000USD | 3,379,000USD | 371,000USD | 573,000USD | 4,118,000USD | 938,000USD | 1,330,000USD | 1,576,000USD |
| Accumulated Other Comprehensive Income | 346,000USD | 66,000USD | 2,000USD | -151,000USD | 0USD | 0USD | -2,000USD | -2,000USD |
| Common Stock Shares Outstanding | 58,544,570shares | 57,870,000shares | 60,372,397shares | 61,097,045shares | 59,205,213shares | 57,847,373shares | 63,678,214shares | 49,239,211shares |
| Non Current Assets Total | 364,617,000USD | 419,948,000USD | 360,378,000USD | 273,585,000USD | 149,004,000USD | 164,183,000USD | 75,206,000USD | 2,598,000USD |
| Non Current Liabilities Total | 149,281,000USD | 164,963,000USD | 180,675,000USD | 192,148,000USD | 193,161,000USD | 195,355,000USD | 98,396,000USD | 523,000USD |
| Non Current Liabilities Other | 5,618,000USD | 1,947,000USD | 2,109,000USD | 2,501,000USD | 3,177,000USD | 893,000USD | 163,000USD | 261,000USD |
| Non Currrent Assets Other | 12,759,000USD | 194,432,000USD | 6,568,000USD | 3,548,000USD | 967,000USD | 902,000USD | 1,691,000USD | 522,000USD |
| Net Working Capital | 654,882,000USD | 404,170,000USD | 287,289,000USD | 321,401,000USD | 230,664,000USD | 128,352,000USD | 11,605,000USD | 79,453,000USD |
| Unclassified Non Current Assets | 149,969,000USD | — | 144,162,000USD | — | -4,265,000USD | — | -1,691,000USD | — |
| Unclassified Current Liabilities | -20,000,000USD | -16,250,000USD | -138,241,000USD | -2,000,000USD | -51,414,000USD | — | — | — |
| Unclassified Equity | 708,967,000USD | 656,871,000USD | 610,265,000USD | 675,117,000USD | 640,103,000USD | 585,373,000USD | — | — |
| Current Deferred Revenue | — | — | 123,241,000USD | — | 49,414,000USD | — | — | — |
| Other Liab | — | — | — | 1,526,000USD | 3,177,000USD | 1,105,000USD | 450,000USD | 523,000USD |
| Other Assets | — | — | — | 87,179,000USD | 4,265,000USD | 902,000USD | 1,691,000USD | 1,022,000USD |
| Net Tangible Assets | — | — | — | 241,885,000USD | 42,588,000USD | -65,163,000USD | -495,047,000USD | -242,673,000USD |
| Unclassified Non Current Liabilities | — | — | — | — | -3,177,000USD | — | — | — |
| Deferred Long Term Liab | — | — | — | — | — | 212,000USD | — | — |
| Property Plant Equipment Gross | — | — | — | — | — | 938,000USD | 1,330,000USD | 1,576,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 32,488,000USD | 22,486,000USD | 50,865,000USD | 39,776,000USD | 45,560,000USD | 49,475,000USD | 46,093,000USD | 11,591,000USD |
| Depreciation | 5,968,000USD | 7,432,000USD | 6,129,000USD | 5,967,000USD | 6,134,000USD | 5,968,000USD | 6,143,000USD | 6,228,000USD |
| Stock Based Compensation | 10,620,000USD | 10,166,000USD | 10,824,000USD | 11,455,000USD | 12,450,000USD | 10,072,000USD | 11,448,000USD | 10,963,000USD |
| Other Non Cash Items | 32,179,000USD | -2,647,000USD | 8,814,000USD | 15,114,000USD | -580,000USD | 943,000USD | -17,038,000USD | 34,490,000USD |
| Change To Account Receivables | -11,435,000USD | 3,864,000USD | -7,670,000USD | 12,988,000USD | -22,936,000USD | -1,531,000USD | 1,655,000USD | -3,438,000USD |
| Change To Inventory | 76,000USD | 1,525,000USD | -782,000USD | 284,000USD | 814,000USD | -283,000USD | -1,272,000USD | 214,000USD |
| Change In Working Capital | -49,632,000USD | 74,037,000USD | 32,102,000USD | 13,500,000USD | -29,577,000USD | 15,816,000USD | 23,855,000USD | -20,655,000USD |
| Total Cash From Operating Activities | 27,760,000USD | 126,151,000USD | 108,734,000USD | 79,327,000USD | 33,987,000USD | 75,562,000USD | 70,501,000USD | 42,617,000USD |
| Capital Expenditures | 0USD | -107,000USD | -71,000USD | -4,000USD | -128,000USD | -513,000USD | -3,000USD | -632,000USD |
| Free Cash Flow | 27,760,000USD | 126,044,000USD | 108,663,000USD | 79,323,000USD | 33,859,000USD | 75,049,000USD | 70,498,000USD | 41,985,000USD |
| Investments | -151,646,000USD | 1,724,000USD | -4,789,000USD | -19,589,000USD | 2,362,000USD | -7,187,000USD | 745,000USD | -54,856,000USD |
| Total Cashflows From Investing Activities | -183,646,000USD | -17,633,000USD | -4,789,000USD | -19,589,000USD | 2,362,000USD | -7,187,000USD | 745,000USD | -54,856,000USD |
| Net Borrowings | -5,000,000USD | -5,000,000USD | -3,750,000USD | -3,750,000USD | -3,750,000USD | -3,750,000USD | -3,750,000USD | — |
| Total Cash From Financing Activities | -7,218,000USD | -3,015,000USD | -2,996,000USD | -2,686,000USD | -352,000USD | -2,741,000USD | -1,175,000USD | -3,446,000USD |
| Change In Cash | -163,104,000USD | 105,503,000USD | 100,949,000USD | 57,052,000USD | 35,997,000USD | 65,634,000USD | 70,071,000USD | -15,685,000USD |
| Begin Period Cash Flow | 752,502,000USD | 647,269,000USD | 546,320,000USD | 489,268,000USD | 453,271,000USD | 387,637,000USD | 317,566,000USD | 333,251,000USD |
| End Period Cash Flow | 589,398,000USD | 752,502,000USD | 647,269,000USD | 546,320,000USD | 489,268,000USD | 453,271,000USD | 387,637,000USD | 317,566,000USD |
| Other Cashflows From Investing Activities | -32,000,000USD | -24,649,000USD | -4,718,000USD | -15,000,000USD | 2,490,000USD | -1,000,000USD | 748,000USD | -21,155,000USD |
| Other Cashflows From Financing Activities | -2,565,000USD | -663,000USD | 754,000USD | -1,033,000USD | 4,706,000USD | 1,009,000USD | 2,575,000USD | 573,000USD |
| Unclassified Operating Cash Flow | -3,863,000USD | 14,677,000USD | — | -6,485,000USD | — | -6,712,000USD | — | — |
| Unclassified Investing Cash Flow | — | 5,399,000USD | 4,789,000USD | 15,004,000USD | -2,362,000USD | 1,513,000USD | — | 21,787,000USD |
| Unclassified Financing Cash Flow | — | 2,648,000USD | — | 2,097,000USD | — | — | — | -3,750,000USD |
| Sale Purchase Of Stock | — | — | — | — | -1,308,000USD | 0USD | 269,000USD | -269,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 158,687,000USD | 145,493,000USD | 128,853,000USD | 181,468,000USD | 34,597,000USD | -36,944,000USD | -151,977,000USD | -39,898,000USD |
| Depreciation | 25,335,000USD | 24,112,000USD | 24,359,000USD | 25,048,000USD | 21,078,000USD | 10,237,000USD | 3,802,000USD | 184,000USD |
| Stock Based Compensation | 44,895,000USD | 42,602,000USD | 31,705,000USD | 26,905,000USD | 16,105,000USD | 4,693,000USD | 9,909,000USD | 1,079,000USD |
| Other Non Cash Items | 27,465,000USD | 44,233,000USD | 12,854,000USD | -82,064,000USD | 24,591,000USD | 4,909,000USD | 59,436,000USD | 2,057,000USD |
| Change To Account Receivables | -13,754,000USD | -8,893,000USD | -19,400,000USD | -19,897,000USD | -12,667,000USD | -17,922,000USD | -4,255,000USD | -4,255,000USD |
| Change To Inventory | 1,841,000USD | -1,835,000USD | -1,066,000USD | 135,000USD | -609,000USD | -2,735,000USD | -1,088,000USD | -1,088,000USD |
| Change In Working Capital | 91,817,000USD | -7,321,000USD | 35,035,000USD | -6,891,000USD | 2,186,000USD | -11,628,000USD | 3,394,000USD | -164,000USD |
| Total Cash From Operating Activities | 348,199,000USD | 219,821,000USD | 219,387,000USD | 144,466,000USD | 98,557,000USD | -2,985,000USD | -75,436,000USD | -38,799,000USD |
| Capital Expenditures | -310,000USD | -1,153,000USD | -312,000USD | -172,000USD | -298,000USD | -2,002,000USD | -149,000USD | -1,342,000USD |
| Free Cash Flow | 347,889,000USD | 218,668,000USD | 219,075,000USD | 144,294,000USD | 98,259,000USD | -4,987,000USD | -75,585,000USD | -40,141,000USD |
| Investments | -5,089,000USD | -67,484,000USD | -57,269,000USD | -141,832,000USD | -100,298,000USD | -2,002,000USD | -127,149,000USD | -1,342,000USD |
| Total Cashflows From Investing Activities | -39,649,000USD | -67,484,000USD | -46,439,000USD | -141,832,000USD | -100,298,000USD | -2,002,000USD | -127,149,000USD | -1,342,000USD |
| Net Borrowings | -16,250,000USD | -15,000,000USD | -1,250,000USD | -2,000,000USD | -500,000USD | 97,462,000USD | 100,000,000USD | 100,000,000USD |
| Total Cash From Financing Activities | -9,049,000USD | -10,996,000USD | -105,552,000USD | 6,841,000USD | 7,419,000USD | 209,161,000USD | 143,769,000USD | 21,615,000USD |
| Sale Purchase Of Stock | 0USD | 0USD | -100,000,000USD | 8,841,000USD | 39,071,000USD | -167,000USD | -1,132,000USD | -3,200,000USD |
| Change In Cash | 299,501,000USD | 141,341,000USD | 67,396,000USD | 9,475,000USD | 5,678,000USD | 204,174,000USD | -58,816,000USD | -18,526,000USD |
| Begin Period Cash Flow | 453,001,000USD | 311,930,000USD | 244,534,000USD | 235,059,000USD | 229,381,000USD | 25,207,000USD | 84,023,000USD | 102,549,000USD |
| End Period Cash Flow | 752,502,000USD | 453,271,000USD | 311,930,000USD | 244,534,000USD | 235,059,000USD | 229,381,000USD | 25,207,000USD | 84,023,000USD |
| Other Cashflows From Investing Activities | -15,000,000USD | -26,500,000USD | — | -141,660,000USD | -100,000,000USD | -2,000,000USD | -127,000,000USD | — |
| Other Cashflows From Financing Activities | -3,004,000USD | -2,497,000USD | -4,302,000USD | 8,841,000USD | 7,919,000USD | 382,584,000USD | 43,769,000USD | 24,815,000USD |
| Unclassified Investing Cash Flow | -19,250,000USD | 27,653,000USD | 11,142,000USD | 141,832,000USD | 100,298,000USD | 4,002,000USD | 127,149,000USD | 1,342,000USD |
| Unclassified Financing Cash Flow | 10,205,000USD | 6,501,000USD | 5,055,000USD | -8,841,000USD | -39,071,000USD | -70,419,000USD | 144,901,000USD | -100,000,000USD |
| Unclassified Operating Cash Flow | — | -29,298,000USD | -13,419,000USD | — | — | 25,748,000USD | — | -2,057,000USD |
| Dividends Paid | — | — | -5,055,000USD | — | — | -200,299,000USD | -143,769,000USD | — |
| Issuance Of Capital Stock | — | — | -408,000USD | 408,000USD | 30,000,000USD | 147,628,000USD | 50,000,000USD | 25,000,000USD |
| Change To Liabilities | — | — | — | 23,204,000USD | -1,555,000USD | -3,804,000USD | 4,898,000USD | -610,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 9,475,000USD | 5,678,000USD | 204,174,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.